These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9928033)

  • 1. Site-directed mutagenesis of human VIP1 versus VIP2 receptors.
    Nicole P; Du K; Couvineau A; Laburthe M
    Ann N Y Acad Sci; 1998 Dec; 865():378-81. PubMed ID: 9928033
    [No Abstract]   [Full Text] [Related]  

  • 2. Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship.
    Nicole P; Du K; Couvineau A; Laburthe M
    J Pharmacol Exp Ther; 1998 Feb; 284(2):744-50. PubMed ID: 9454823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
    Gourlet P; Vandermeers A; Van Rampelbergh J; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
    Ann N Y Acad Sci; 1998 Dec; 865():247-52. PubMed ID: 9928018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of the human VIP1 receptor.
    Gaudin P; Rouyer-Fessard C; Couvineau A; Maoret JJ; Laburthe M
    Ann N Y Acad Sci; 1998 Dec; 865():382-5. PubMed ID: 9928034
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of cysteine residues in the N-terminal extracellular domain of the human VIP 1 receptor for ligand binding. A site-directed mutagenesis study.
    Gaudin P; Couvineau A; Maoret JJ; Rouyer-Fessard C; Laburthe M
    Ann N Y Acad Sci; 1996 Dec; 805():585-9. PubMed ID: 8993444
    [No Abstract]   [Full Text] [Related]  

  • 6. [Directed mutagenesis of human recombinant receptors of vasoactive intestinal peptide of VIP1 and VIP2 type. Difference in structure-activity relationship].
    Nicole P; Du K; Couvineau A; Laburthe M
    Gastroenterol Clin Biol; 1997; 21(5):365-9. PubMed ID: 9208011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.
    Du K; Nicole P; Couvineau A; Laburthe M
    Biochem Biophys Res Commun; 1997 Jan; 230(2):289-92. PubMed ID: 9016768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different domains of the VIP receptors modulate agonist affinity and intrinsic activity.
    Juarranz MG; Van Rampelbergh J; Gourlet P; Waelbroeck M; Robberecht P
    Ann N Y Acad Sci; 2000; 921():395-9. PubMed ID: 11193863
    [No Abstract]   [Full Text] [Related]  

  • 9. VIP1 and VIP2 receptors but not PVR1 mediate the effect of VIP/PACAP on cytokine production in T lymphocytes.
    Jiang X; Wang HY; Yu J; Ganea D
    Ann N Y Acad Sci; 1998 Dec; 865():397-407. PubMed ID: 9928038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.
    Vertongen P; Solano RM; Perret J; Langer I; Robberecht P; Waelbroeck M
    Br J Pharmacol; 2001 Aug; 133(8):1249-54. PubMed ID: 11498510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional roles of conserved transmembrane prolines in the human VPAC(1) receptor.
    Knudsen SM; Tams JW; Fahrenkrug J
    FEBS Lett; 2001 Aug; 503(2-3):126-30. PubMed ID: 11513868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of conserved cysteines in the extracellular loops of human PACAP/VIP1 receptor for ligand binding and stimulation of cAMP production.
    Knudsen SM; Tams JW; Wulff BS; Fahrenkrug J
    Ann N Y Acad Sci; 1998 Dec; 865():259-65. PubMed ID: 9928020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of chimeras between human VIP1 and secretin receptors: identification of receptor domains involved in selectivity towards VIP, secretin, and PACAP.
    Du K; Nicole P; Couvineau A; Laburthe M
    Ann N Y Acad Sci; 1998 Dec; 865():386-9. PubMed ID: 9928035
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of second extracellular loop in the function of human vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide receptor 1 (hVPAC1R).
    Knudsen SM; Tams JW; Fahrenkrug J
    J Mol Neurosci; 2000 Jun; 14(3):137-46. PubMed ID: 10984189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain.
    Vertongen P; Schiffmann SN; Gourlet P; Robberecht P
    Peptides; 1997; 18(10):1547-54. PubMed ID: 9437715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions.
    Usdin TB; Bonner TI; Mezey E
    Endocrinology; 1994 Dec; 135(6):2662-80. PubMed ID: 7988457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase C activation by VIP1 and VIP2 receptors expressed in COS 7 cells involves a pertussis toxin-sensitive mechanism.
    MacKenzie CJ; Lutz EM; McCulloch DA; Mitchell R; Harmar AJ
    Ann N Y Acad Sci; 1996 Dec; 805():579-84. PubMed ID: 8993443
    [No Abstract]   [Full Text] [Related]  

  • 18. Alanine scanning of VIP. Structure-function relationship for binding to human recombinant VPAC1 receptor.
    Nicole P; Rouyer-Fessard C; Couvineau A; Drouot C; Fulcrand P; Martinez J; Laburthe M
    Ann N Y Acad Sci; 2000; 921():352-6. PubMed ID: 11193851
    [No Abstract]   [Full Text] [Related]  

  • 19. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
    Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequences (103-110) and (116-120) of the rat secretin receptor are implicated in secretin and VIP recognition.
    Robberecht P; Di Paolo E; Moguilevsky N; Bollen A; Waelbroeck M
    Ann N Y Acad Sci; 2000; 921():362-5. PubMed ID: 11193853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.